(Q51193892)

1 April 2018

title

Selection of Candida glabrata strains with reduced susceptibility to azoles in four liver transplant patients with invasive candidiasis. (English)

1 reference

1 April 2018

0 references

1 reference

1 reference

J Fortún

1

1 reference

1 April 2018

A López-San Román

2

1 reference

1 April 2018

J J Velasco

3

1 reference

1 April 2018

A Sánchez-Sousa

4

1 reference

1 April 2018

E de Vicente

5

1 reference

1 April 2018

J Nuño

6

1 reference

1 April 2018

C Quereda

7

1 reference

1 April 2018

R Bárcena

8

1 reference

1 April 2018

G Monge

9

1 reference

1 April 2018

A Candela

10

1 reference

1 April 2018

A Honrubia

11

1 reference

1 April 2018

A Guerrero

12

1 reference

1 April 2018

language of work or name

1 reference

1 April 1997

1 reference

1 April 2018

number of pages

5

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

inferred from page(s)

published in

1 reference

1 April 2018

volume

16

1 reference

1 April 2018

issue

4

1 reference

1 April 2018

page(s)

314-318

1 reference

1 April 2018

https://scigraph.springernature.com/pub.10.1007/bf01695638

exact match

0 references

cites work

Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial.

1 reference

https://api.crossref.org/works/10.1007%2FBF01695638

Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01695638

Failure of fluconazole to suppress fungemia in a patient with fever, neutropenia, and typhlitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01695638

Fungal infections in solid-organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01695638

Azole resistance in oropharyngeal Candida albicans strains isolated from patients infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01695638

Antifungal susceptibility testing of yeasts: evaluation of technical variables for test automation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01695638

Antimicrobial susceptibility testing of yeasts: a turbidimetric technique independent of inoculum size

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01695638

Characterization of an azole-resistant Candida glabrata isolate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01695638

Fluconazole resistance in Candida glabrata

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01695638

Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection.

21 January 2018

1 reference

12 December 2020

Changes in the spectrum of fungal isolates: results from clinical specimens gathered in 1987/88 compared with those in 1991/92 in the University Hospital Göttingen, Germany

1 reference

12 December 2020

Drug resistance in the opportunistic pathogens Candida albicans and Candida glabrata.

1 reference

12 December 2020

In vitro susceptibility of yeast isolates from the blood to fluconazole and amphotericin B

1 reference

12 December 2020

The effect of fluconazole prophylaxis on fungal colonization in neutropenic cancer patients. Bone Marrow Transplantation Team

1 reference

12 December 2020

A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation

1 reference

12 December 2020

Management of persistent vulvo vaginal candidosis due to azole-resistant Candida glabrata.

1 reference

12 December 2020

Surveillance tests for the diagnosis of invasive fungal infections in bone marrow transplant recipients

1 reference

12 December 2020

In vitro susceptibility of 119 yeast isolates to fluconazole, 5-fluorocytosine, amphotericin B and ketoconazole

1 reference

12 December 2020

Testing susceptibility of fungi to fluconazole

1 reference

12 December 2020

Correlation between in vitro resistance to fluconazole and clinical outcome of oropharyngeal candidiasis in HIV-infected patients.

1 reference

12 December 2020

Defining conditions for microbroth antifungal susceptibility tests: influence of RPMI and RPMI-2% glucose on the selection of endpoint criteria.

1 reference

12 December 2020

Increase inCandida kruseiInfection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole

1 reference

12 December 2020

Fluconazole and Candida krusei fungemia.

1 reference

12 December 2020

In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole

1 reference

12 December 2020

Fluconazole resistance in Candida glabrata

1 reference

12 December 2020

Therapy for oropharyngeal candidiasis in the immunocompromised host: a randomized double-blind study of fluconazole vs. ketoconazole.

1 reference

12 December 2020

Comparison of a spectrophotometric microdilution method with RPMI-2% glucose with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro susceptibility testing of amphotericin B, flucytosine, and f

1 reference

12 December 2020

Improved method of determining the susceptibility of Candida albicans to fluconazole

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01695638

1 reference

1 April 2018

1 reference

1 April 2018